# Tembexa

NDC: 64678-012
Generic name: Brincidofovir
Labeler / Manufacturer: Emergent BioDefense Operations Lansing LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20220420

FDA application: NDA214460

## Active ingredients

- BRINCIDOFOVIR: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64678-012"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64678-012
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0784838e-00bd-4b14-9b7e-653b7fbb7eea